DrugPatentWatch Database Preview
Ceftriaxone sodium - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for ceftriaxone sodium and what is the scope of freedom to operate?
Ceftriaxone sodium
is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Agila Speclts, Aurobindo Pharma Ltd, Bedford, Facta Farma, Fresenius Kabi Usa, Hospira Inc, Lupin, Qilu, Samson Medcl, Sandoz, Sandoz Inc, Teva, Wockhardt, B Braun, Baxter Hlthcare, Astral, Hikma, Hoffmann La Roche, Roche, Akorn Inc, Cephazone Pharma, Hikma Farmaceutica, and Teva Pharms Usa, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-six drug master file entries for ceftriaxone sodium. Twenty-one suppliers are listed for this compound.
Summary for ceftriaxone sodium
| US Patents: | 0 |
| Tradenames: | 7 |
| Applicants: | 24 |
| NDAs: | 41 |
| Drug Master File Entries: | 26 |
| Suppliers / Packagers: | 21 |
| Bulk Api Vendors: | 81 |
| Clinical Trials: | 16 |
| Patent Applications: | 7,402 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ceftriaxone sodium at DailyMed |
Recent Clinical Trials for ceftriaxone sodium
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of British Columbia | Early Phase 1 |
| Fayoum University Hospital | Phase 4 |
| Xiangbei Welman Pharmaceutical Co., Ltd | Phase 4 |
Pharmacology for ceftriaxone sodium
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for ceftriaxone sodium
US Patents and Regulatory Information for ceftriaxone sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065169-003 | May 9, 2005 | AP | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Hoffmann La Roche | ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050624-003 | Feb 11, 1987 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Astral | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 091049-002 | Jun 11, 2018 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Facta Farma | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065268-002 | Feb 28, 2007 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
